Details
Stereochemistry | RACEMIC |
Molecular Formula | C14H23NO2 |
Molecular Weight | 237.3379 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(CC1=CC(C)=CC(=O)N1O)CC(C)(C)C
InChI
InChIKey=OIQJEQLSYJSNDS-UHFFFAOYSA-N
InChI=1S/C14H23NO2/c1-10-6-12(15(17)13(16)8-10)7-11(2)9-14(3,4)5/h6,8,11,17H,7,9H2,1-5H3
Molecular Formula | C14H23NO2 |
Molecular Weight | 237.3379 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Piroctone olamine is used in combination with other substances as a part of shampoo effectively reduced the amount of dandruff and, at the same time, provided hair conditioning advantages. Recently was shown, that piroctone olamine could induce apoptosis and possessed a significant in vivo effect against myeloma.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21282741 |
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Nudging hair shedding by antidandruff shampoos. A comparison of 1% ketoconazole, 1% piroctone olamine and 1% zinc pyrithione formulations. | 2002 Oct |
|
Effect of residence time on the efficacy of antidandruff shampoos. | 2003 Dec |
|
Enhanced delivery of an anti-dandruff active in a shampoo vehicle. | 2004 |
|
In vitro antimycotic activity and nail permeation models of a piroctone olamine (octopirox) containing transungual water soluble technology. | 2005 |
|
[Determination of antidangdruff agent salicylic acid, zinc pyrithione, octopirox, climbazole and ketoconazole in shampoo by high performance liquid chromatography]. | 2005 Sep |
|
In vitro investigations on the mode of action of the hydroxypyridone antimycotics rilopirox and piroctone on Candida albicans. | 2006 May |
|
Treatment of mild to moderate seborrhoeic dermatitis with MAS064D (Sebclair), a novel topical medical device: results of a pilot, randomized, double-blind, controlled trial. | 2008 Mar |
|
The in vitro effect of a collagenolytic enzyme inhibitor on lesion development in root dentin. | 2009 Apr |
|
Allergic contact dermatitis to propyl gallate and pentylene glycol in an emollient cream. | 2010 May |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21272039
shampoo
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21282741
Curator's Comment: It was demonstrated, that piroctone olamine had a major apoptotic activity in various human and murine myeloma and lymphoma cell lines, as well as in human primary cells.
Unknown
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:23:51 GMT 2023
by
admin
on
Fri Dec 15 16:23:51 GMT 2023
|
Record UNII |
R49EFA73Q7
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C78284
Created by
admin on Fri Dec 15 16:23:51 GMT 2023 , Edited by admin on Fri Dec 15 16:23:51 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
R49EFA73Q7
Created by
admin on Fri Dec 15 16:23:51 GMT 2023 , Edited by admin on Fri Dec 15 16:23:51 GMT 2023
|
PRIMARY | |||
|
R49EFA73Q7
Created by
admin on Fri Dec 15 16:23:51 GMT 2023 , Edited by admin on Fri Dec 15 16:23:51 GMT 2023
|
PRIMARY | |||
|
50259
Created by
admin on Fri Dec 15 16:23:51 GMT 2023 , Edited by admin on Fri Dec 15 16:23:51 GMT 2023
|
PRIMARY | |||
|
50650-76-5
Created by
admin on Fri Dec 15 16:23:51 GMT 2023 , Edited by admin on Fri Dec 15 16:23:51 GMT 2023
|
PRIMARY | |||
|
4808
Created by
admin on Fri Dec 15 16:23:51 GMT 2023 , Edited by admin on Fri Dec 15 16:23:51 GMT 2023
|
PRIMARY | |||
|
2058907
Created by
admin on Fri Dec 15 16:23:51 GMT 2023 , Edited by admin on Fri Dec 15 16:23:51 GMT 2023
|
PRIMARY | |||
|
59009
Created by
admin on Fri Dec 15 16:23:51 GMT 2023 , Edited by admin on Fri Dec 15 16:23:51 GMT 2023
|
PRIMARY | |||
|
DTXSID2048298
Created by
admin on Fri Dec 15 16:23:51 GMT 2023 , Edited by admin on Fri Dec 15 16:23:51 GMT 2023
|
PRIMARY | |||
|
SUB09927MIG
Created by
admin on Fri Dec 15 16:23:51 GMT 2023 , Edited by admin on Fri Dec 15 16:23:51 GMT 2023
|
PRIMARY | |||
|
CHEMBL1473700
Created by
admin on Fri Dec 15 16:23:51 GMT 2023 , Edited by admin on Fri Dec 15 16:23:51 GMT 2023
|
PRIMARY | |||
|
3479
Created by
admin on Fri Dec 15 16:23:51 GMT 2023 , Edited by admin on Fri Dec 15 16:23:51 GMT 2023
|
PRIMARY | |||
|
100000081694
Created by
admin on Fri Dec 15 16:23:51 GMT 2023 , Edited by admin on Fri Dec 15 16:23:51 GMT 2023
|
PRIMARY | |||
|
C66429
Created by
admin on Fri Dec 15 16:23:51 GMT 2023 , Edited by admin on Fri Dec 15 16:23:51 GMT 2023
|
PRIMARY | |||
|
m8885
Created by
admin on Fri Dec 15 16:23:51 GMT 2023 , Edited by admin on Fri Dec 15 16:23:51 GMT 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |